Breaking: dementia gene-based therapies on the rise in the UK
Collaboration between UK-based Cell & Gene Therapy Catapult and the UK Dementia Research Institute is currently set to allow academic centers to identify new AAV-based gene therapies with high potential to become new medicines for dementia. Labiotech discloses more information in a recent article, here.
Responses